Salvia plebeia R.Br. and Rosmarinic Acid Attenuate Dexamethasone-Induced Muscle Atrophy in C2C12 Myotubes
International Journal of Molecular Sciences · 18.01.2023 · 24 (3) · 1876
DOI: 10.3390/ijms24031876 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.01.2023. Verfasst von Jae-Yong Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 426-791, Gyeonggi-do, Republic of Korea. Hauptthemen laut MEDLINE: Dexamethasone, Muscle Fibers, Skeletal. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Skeletal muscle atrophy occurs when protein degradation exceeds protein synthesis and is associated with increased circulating glucocorticoid levels. Salvia plebeia R.Br. (SPR) has been used as herbal remedy for a variety of inflammatory diseases and has various biological actions such as antioxidant and anti-inflammatory activities. However, there are no reports on the effects of SPR and its bioactive components on muscle atrophy. Herein, we investigated the anti-atrophic effect of SPR and rosmarinic acid (RosA), a major compound of SPR, on dexamethasone (DEX)-induced skeletal muscle atrophy in C2C12 myotubes. Myotubes were treated with 10 μM DEX in the presence or absence of SPR or RosA at different concentrations for 24 h and subjected to immunocytochemistry, western blot, and measurements of ROS and ATP levels. SPR and RosA increased viability and inhibited protein degradation in DEX-treated C2C12 myotubes. In addition, RosA promoted the Akt/p70S6K/mTOR pathway and reduced ROS production, and apoptosis. Furthermore, the treatment of RosA significantly recovered SOD activity, autophagy activity, mitochondrial contents, and APT levels in DEX-treated myotubes. These findings suggest that SPR and RosA may provide protective effects against DEX-induced muscle atrophy and have promising potential as a nutraceutical remedy for the treatment of muscle weakness and atrophy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 426-791, Gyeonggi-do, Republic of Korea.
ORCID-Profile: Ji Hoon Kim, Chul Young Kim
Förderung
- National Research Foundation of Korea
Zitieren
APA
Kim, J. Y., Kim, H. M., Kim, J. H., Guo, S., Lee, D. H., Lim, G. M., Kim, W., & Kim, C. Y. (2023). Salvia plebeia R.Br. and Rosmarinic Acid Attenuate Dexamethasone-Induced Muscle Atrophy in C2C12 Myotubes. International Journal of Molecular Sciences, 24(3), 1876. https://doi.org/10.3390/ijms24031876
Vancouver
Kim JY, Kim HM, Kim JH, Guo S, Lee DH, Lim GM, et al. Salvia plebeia R.Br. and Rosmarinic Acid Attenuate Dexamethasone-Induced Muscle Atrophy in C2C12 Myotubes. International Journal of Molecular Sciences. 2023;24(3):1876. doi:10.3390/ijms24031876
BibTeX
@article{Kim2023,
author = {Kim, Jae-Yong and Kim, Hye Mi and Kim, Ji Hoon and Guo, Shuo and Lee, Do Hyun and Lim, Gyu Min and Kim, Wondong and Kim, Chul Young},
title = {Salvia plebeia R.Br. and Rosmarinic Acid Attenuate Dexamethasone-Induced Muscle Atrophy in C2C12 Myotubes},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {3},
pages = {1876},
doi = {10.3390/ijms24031876}
}
EUVIMED